Items where Author is "Pfoehler, C."

Article

Klespe, K. C. and Kochanek, C. and Schadendorf, D. and Ugurel, S. and Mohr, P. and Meier, F. and Weichenthal, M. and Pfoehler, C. and Haferkamp, S. and Herbst, R. and Terheyden, P. and Meiss, F. and Ulrich, J. and Utikal, J. S. and Leiter-Stoeppke, U. and Gutzmer, R. and von Wasielewski, I. (2023) Influence of BRAF mutation status on the effectiveness of immune checkpoint inhibition in metastatic melanoma - a multicenter study from the ADOREG. JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT, 21. pp. 28-29. ISSN 1610-0379, 1610-0387

Kochanek, C. and Livingstone, E. and Ugurel, S. and Meier, F. and Mohr, P. and Terheyden, P. and Haferkamp, S. and Kaatz, M. and Sachse, M. M. and Meiss, F. and Pfoehler, C. and Leiter-Stoeppke, U. and Ulrich, J. and Schadendorf, D. and Weichenthal, M. and Angela, Y. and Schaper-Gerhardt, K. and Gutzmer, R. (2023) Influence of osteoprotective therapy on the effectiveness of immune checkpoint inhibition in melanoma - an evaluation of the ADOReg. JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT, 21. pp. 49-50. ISSN 1610-0379, 1610-0387

Gutzmer, R. and Ugurel, S. and Eigentler, T. and Mohr, P. and Weichenthal, M. and Gebhardt, C. and Goeppner, D. and Haferkamp, S. and Herbst, R. and Kaehler, K. C. and Kreuter, A. and Meier, F. and Pfoehler, C. and Sachse, M. M. and Herber, M. and Terheyden, P. and Ulrich, J. and Utikal, J. S. and von Wasielewski, I. and Schadendorf, D. (2023) Relationship between baseline health-related quality of life (HRQoL) measures and clinical outcomes of nivolumab (NIVO) or nivolumab plus ipilimumab (NIVO plus IPI) in patients (pts) with unresectable or metastatic melanoma using real-world data from the non-interventional study (NIS) NICO in Germany. JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT, 21. pp. 6-8. ISSN 1610-0379, 1610-0387

Conference or Workshop Item

Weichenthal, M. and Mohr, P. and Leiter-Stoeppke, U. and Ugurel, S. and Kaehler, K. and Gutzmer, R. and Pfoehler, C. and Hassel, J. C. and Nashan, D. and Terheyden, P. and Schell, B. and Utikal, J. S. and Kreuter, A. and Haferkamp, S. and Kaune, K. and Berking, C. and Debus, D. and Ulrich, J. and Dabrowski, E. and Eigentler, T. and Welzel, J. and Herbst, R. and Loquai, C. and Meier, F. and Schadendorf, D. (2021) The Effects of Brain Metastases in Melanoma Patients on anti-PD1 Antibody Therapy with Pembrolizumab. In: 31. Deutscher Hautkrebskongress (ADO-Jahrestagung), 8.–11. September 2021, hybrid.

Spassova, I. and Ugurel, S. and Zimmer, L. and Schadendorf, D. and Terheyden, P. and Andtback, H. B. and Villabona, L. and Leiter-Stoeppke, U. and Eigentler, T. and Loquai, C. and Hassel, J. C. and Gambichler, T. and Haferkamp, S. and Mohr, P. and Pfoehler, C. and Heinzerling, L. and Horny, K. and Habermann, D. and Hoffmann, D. and Becker, J. C. (2020) Immune-Checkpoint-Blockade for Merkel Cell Carcinoma: Clinical and molecular Biomarker-Analysis. In: 30. Deutscher Hautkrebskongress (ADO‐Jahrestagung), 9. bis 12. September 2020, Virtuell.

Gilde, C. and Ugurel, S. and Mohr, P. and Weichenthal, M. and Terheyden, P. and Meier, F. and Pfoehler, C. and Leiter-Stoeppke, U. and Kaatz, M. and Haferkamp, S. and Ulrich, J. and Kochanek, C. and Schadendorf, D. and Gutzmer, R. (2020) Influence of the BRAF-V600 Mutation Status on the Efficiency of an Immune Checkpoint Blockade - an Evaluation of the ADOREG. In: 30. Deutscher Hautkrebskongress (ADO‐Jahrestagung), 9. bis 12. September 2020, Virtuell.

Gutzmer, R. and Eigentler, T. and Mohr, P. and Weichenthal, M. and Duecker, P. and Gebhardt, C. and Goeppner, D. and Haferkamp, S. and Kaehler, K. and Meier, F. and Pfoehler, C. and Satzger, I. and Sickmann, T. and Sindrilaru, A. and Terheyden, P. and Ugurel, S. and Ulrich, J. and Utikal, J. and Weishaupt, C. and Schadendorf, D. (2020) Nivolumab (NIVO) monotherapy or combination therapy with ipilimumab (NIVO plus IPI) in advanced melanoma patients with brain metastases: Real-world evidence from the German non-interventional study NICO. In: ESMO Virtual Congress, SEP 19-OCT 18, 2020, ELECTR NETWORK.

Other

Zaremba, A. and Weishaupt, C. and Glutsch, V. and Schilling, B. and Loquai, C. and Rafei-Shamsabadi, D. and Meiss, F. and Gutzmer, R. and Haferkamp, S. and Kaehler, K. and Moreira, A. and Heinzerling, L. and Thoms, K. M. and Kiecker, F. and Pfoehler, C. and Ugurel, S. and Roesch, A. and Zimmer, L. and Schadendorf, D. and Livingstone, E. (2019) Characterization of Patients with inoperable malignant Stage IIIB-D Melanoma. WILEY, HOBOKEN.

Leiter-Stoeppke, U. and Loquai, C. and Meier, F. and Rafei-Shamsabadi, D. and Hassel, J. and Glutsch, V. and Sirokay, J. and Schlecht, N. and Ruebben, A. and Gutzmer, R. and Kaehler, K. and Gambichler, T. and Schatton, K. and Pfoehler, C. and Franklin, C. and Terheyden, P. and Haferkamp, S. and Mohr, P. and Heinzerling, L. and Meiwes, A. and Keim, U. and Becker, J. C. and Bischof, L. and Livingstone, E. and Schadendorf, D. and Ugurel, S. (2019) Limited Effect of Anti-PD-1 in advanced Skin Tumors of Patients with hemato-oncological Primary Disease: A retrospective multi-center Study of ADO. WILEY, HOBOKEN.

Weichenthal, M. and Gutzmer, R. and Eigentler, T. and Mohr, P. and Goeppner, D. and Haferkamp, S. and Herber, M. and Herbst, R. and Meier, F. and Meiss, F. and Pfoehler, C. and Schneider, S. W. and Terheyden, P. and Ulrich, J. and Utikal, J. and Weishaupt, C. and Welzel, J. and Schadendorf, D. (2019) Real-world Data on advanced Melanoma: First Data from a national, prospective, non-interventional Study of Nivolumab in Combination with Ipilimumab or as Nivolumab Monotherapy (NICO). WILEY, HOBOKEN.

Gutzmer, R. and Eigentler, T. and Mohr, P. and Becker, S. and Haferkamp, S. and Meiss, F. and Pfoehler, C. and Satzger, I. and Schneider, S. W. and Terheyden, P. and Ulrich, J. and Utikal, J. and Weichenthal, M. and Weishaupt, C. and Zimmer, L. and Schadendorf, D. (2018) NICO - a national prospective non-interventional Study (NIS) with Nivolumab as Monotherapy or in combination with Ipilimumab in Patients with advanced (inoperable or metastatic) Melanoma to collect real-world data. WILEY, HOBOKEN.